{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:47:26Z","timestamp":1778874446612,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nmcd-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.numecd.2018.01.012","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T08:38:16Z","timestamp":1517560696000},"page":"517-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lipoprotein-associated phospholipase A\u2082 activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3458-0894","authenticated-orcid":false,"given":"A.","family":"Mattina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bittar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bonnefont-Rousselot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Noto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Averna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bruckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Giral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2018.01.012_bib1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pharma.2015.09.002","article-title":"Lp-PLA2, a biomarker of vascular inflammation and vulnerability of atherosclerosis plaques","volume":"74","author":"Bonnefont-Rousselot","year":"2016","journal-title":"Ann Pharm Fr"},{"issue":"10","key":"10.1016\/j.numecd.2018.01.012_bib2","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.1074\/jbc.M709970200","article-title":"Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein","volume":"283","author":"Davis","year":"2008","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.numecd.2018.01.012_bib3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/01.ATV.16.4.591","article-title":"Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins","volume":"16","author":"Tew","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.numecd.2018.01.012_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0021-9150(99)00406-2","article-title":"Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease","volume":"150","author":"Caslake","year":"2000","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.numecd.2018.01.012_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/01.ATV.0000191655.87296.ab","article-title":"Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans","volume":"26","author":"Yang","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.numecd.2018.01.012_bib6","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/01.ATV.0000244681.72738.bc","article-title":"Lipoprotein-associated phospholipase A2 protein expression in the natural progression of\u00a0human coronary atherosclerosis","volume":"26","author":"Kolodgie","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.numecd.2018.01.012_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00015458.2007.11680029","article-title":"From Carotid plaque biology to serologic markers of vulnerability to predict the risk of cerebrovascular events","volume":"107","author":"Cola","year":"2007","journal-title":"Acta Chir Belg"},{"issue":"12 SUPPL","key":"10.1016\/j.numecd.2018.01.012_bib8","article-title":"Identifying the vulnerable patient with rupture-prone plaque","volume":"101","author":"Weintraub","year":"2008","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.numecd.2018.01.012_bib9","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/ATVBAHA.112.249854","article-title":"Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation","volume":"32","author":"Gon\u00e7alves","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2018.01.012_bib10","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","article-title":"Lipoprotein-associated phospholipase A 2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies","volume":"375","author":"Thompson","year":"2010","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.numecd.2018.01.012_bib11","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/eurheartj\/eht015","article-title":"Diagnosis and treatment of familial hypercholesterolaemia","volume":"34","author":"Hovingh","year":"2013","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.numecd.2018.01.012_bib12","first-page":"96","article-title":"Carotid atherosclerosis in hypercholesterolemic patients: relationship with cardiovascular events","volume":"11","author":"Parrinello","year":"2001","journal-title":"NutrMetab Cardiovasc"},{"issue":"2","key":"10.1016\/j.numecd.2018.01.012_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-2007-994021","article-title":"Endothelium-derived nitric oxide, endothelin, and platelet vessel wall interaction: alterations in hypercholesterolemia and atherosclerosis","volume":"19","author":"Tanner","year":"1993","journal-title":"Semin Thromb Hemost"},{"issue":"11","key":"10.1016\/j.numecd.2018.01.012_bib14","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1365-2362.2001.00915.x","article-title":"Impact of genetic defects on atherosclerosis in patients suspected of familial hypercholesterolaemia","volume":"31","author":"Descamps","year":"2001","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1016\/j.numecd.2018.01.012_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/aje\/kwh237","article-title":"Familial hypercholesterolemia and coronary heart disease: a HuGE association review","volume":"160","author":"Austin","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/j.numecd.2018.01.012_bib16","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6807","key":"10.1016\/j.numecd.2018.01.012_bib17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Risk of fatal coronary heart disease in familial hypercholesterolaemia","volume":"303","author":"Scientific Steering Committe on behalf of the Simon Broome Register Group","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.numecd.2018.01.012_bib18","series-title":"Familial hypercholesterolaemia (fm) - Report of a second WHO consultation","author":"Organization WH","year":"1999"},{"issue":"45","key":"10.1016\/j.numecd.2018.01.012_bib19","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.numecd.2018.01.012_bib20","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/clinchem\/28.10.2077","article-title":"Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide","volume":"28","author":"Fossati","year":"1982","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.numecd.2018.01.012_bib21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","article-title":"Enzymatic determination of total serum cholesterol","volume":"20","author":"Allain","year":"1974","journal-title":"Clin Chem"},{"issue":"5","key":"10.1016\/j.numecd.2018.01.012_bib22","first-page":"561","article-title":"Multicenter evaluation on different analyzers of three methods for direct HDL-cholesterol assay","volume":"57","author":"Egloff","year":"1999","journal-title":"Ann Biol Clin (Paris)"},{"issue":"1","key":"10.1016\/j.numecd.2018.01.012_bib23","first-page":"27","article-title":"Multicenter evaluation of four\u00a0homogenous LDL-cholesterol assays","volume":"63","author":"Bayer","year":"2005","journal-title":"Ann Biol Clin"},{"issue":"6","key":"10.1016\/j.numecd.2018.01.012_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"5","key":"10.1016\/j.numecd.2018.01.012_bib25","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/clinchem\/38.5.658","article-title":"International federation of clinical chemistry standardization project for measurements of apolipoproteins A-I and B. II. Evaluation and selection of candidate reference materials","volume":"38","author":"Albers","year":"1992","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.numecd.2018.01.012_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2009.10.041","article-title":"Lipoprotein-associated phospholipase A2, inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)","volume":"210","author":"Caslake","year":"2010","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.numecd.2018.01.012_bib27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0022-2275(20)30167-X","article-title":"Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia","volume":"43","author":"Tsimihodimos","year":"2002","journal-title":"J Lipid Res"},{"issue":"12","key":"10.1016\/j.numecd.2018.01.012_bib28","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1373\/clinchem.2005.058404","article-title":"Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma","volume":"51","author":"Gazi","year":"2005","journal-title":"Clin Chem"},{"issue":"10","key":"10.1016\/j.numecd.2018.01.012_bib29","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1161\/01.ATV.15.10.1764","article-title":"PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme","volume":"15","author":"Tselepis","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.numecd.2018.01.012_bib30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clinbiochem.2015.09.002","article-title":"Advantages of the lipoprotein-associated phospholipase A2 activity assay","volume":"49","author":"Donato","year":"2016","journal-title":"Clin Biochem"},{"issue":"1","key":"10.1016\/j.numecd.2018.01.012_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1194\/jlr.M030221","article-title":"Structural basis of specific interactions of Lp-PLA2 with HDL revealed by hydrogen deuterium exchange mass spectrometry","volume":"54","author":"Cao","year":"2013","journal-title":"J Lipid Res"},{"issue":"40","key":"10.1016\/j.numecd.2018.01.012_bib32","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.2174\/1381612820666140622200916","article-title":"Pathophysiological role and clinical significance of lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) bound to LDL and HDL","volume":"20","author":"Tellis","year":"2014","journal-title":"Curr Pharmaceut Des"},{"issue":"6","key":"10.1016\/j.numecd.2018.01.012_bib33","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1074\/jbc.M211126200","article-title":"Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles","volume":"278","author":"Marathe","year":"2003","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.numecd.2018.01.012_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.ATV.21.4.481","article-title":"HDL and the inflammatory response induced by LDL-derived oxidized phospholipids","volume":"21","author":"Navab","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.numecd.2018.01.012_bib35","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ejim.2014.05.010","article-title":"Unexpected inverse relationship between impaired glucose metabolism and lipoprotein-associated phospholipase A2 activity in patients with stable vascular disease","volume":"25","author":"Mayer","year":"2014","journal-title":"Eur J Intern Med"},{"issue":"8","key":"10.1016\/j.numecd.2018.01.012_bib36","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1515\/CCLM.2011.110","article-title":"Dual activity of serum lipoprotein-associated phospholipase A(2) yielding positive and inverse associations with cardiometabolic risk","volume":"49","author":"Onat","year":"2011","journal-title":"Clin Chem Lab Med"},{"issue":"10","key":"10.1016\/j.numecd.2018.01.012_bib37","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1194\/jlr.D300021-JLR200","article-title":"Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus","volume":"44","author":"Kujiraoka","year":"2003","journal-title":"J Lipid Res"},{"issue":"10","key":"10.1016\/j.numecd.2018.01.012_bib38","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0022-2275(20)32219-7","article-title":"N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDL","volume":"42","author":"Tselepis","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2018.01.012_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.atherosclerosis.2015.12.027","article-title":"Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population","volume":"246","author":"Ueshima","year":"2016","journal-title":"Atherosclerosis"},{"issue":"February","key":"10.1016\/j.numecd.2018.01.012_bib40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0025-6196(11)60992-0","article-title":"Association between lipoprotein-associated phospholipase A 2 and cardiovascular disease: a systematic review","volume":"82","author":"Garza","year":"2007","journal-title":"Mayo Clin"},{"issue":"5","key":"10.1016\/j.numecd.2018.01.012_bib41","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1210\/jc.2004-2027","article-title":"Clinical review: lipoprotein-associated phospholipase A2, a novel inflammatory biomarker and independent risk predictor for cardiovascular disease","volume":"90","author":"Sudhir","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"10.1016\/j.numecd.2018.01.012_bib42","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1056\/NEJM199705013361802","article-title":"Coronary risk factors and plaque morphology in men with coronary disease who died suddenly","volume":"336","author":"Burke","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.numecd.2018.01.012_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00043798-199602000-00009","article-title":"The extracranial carotid artery in familial hypercholesterolaemia: relationship of intimal-medial thickness and plaque morphology with plasma lipids and coronary heart disease","volume":"3","author":"Sidhu","year":"1996","journal-title":"J Cardiovasc Risk"},{"issue":"2","key":"10.1016\/j.numecd.2018.01.012_bib44","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.atherosclerosis.2012.02.043","article-title":"Detection of subclinical atherosclerosis in familial hypercholesterolemia using non-invasive imaging modalities","volume":"222","author":"Caballero","year":"2012","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.numecd.2018.01.012_bib45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.atherosclerosis.2013.08.040","article-title":"Assessment of subclinical atherosclerosis and intraplaque neovascularization using quantitative contrast-enhanced ultrasound in patients with familial hypercholesterolemia","volume":"231","author":"Van Den Oord","year":"2013","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.numecd.2018.01.012_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003407","article-title":"Lipoprotein-associated phospholipase A2 activity is a marker of risk but not a useful target for treatment in patients with stable coronary heart disease","volume":"5","author":"Wallentin","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.numecd.2018.01.012_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11883-009-0074-y","article-title":"Lp-PLA2: a new target for statin therapy","volume":"12","author":"Braun","year":"2010","journal-title":"Curr Atherosclerosis Rep"},{"issue":"1","key":"10.1016\/j.numecd.2018.01.012_bib48","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jacl.2010.11.001","article-title":"Lipoprotein-associated phospholipase A2 mass and activity in children with heterozygous familial hypercholesterolemia and unaffected siblings: effect of pravastatin","volume":"5","author":"Ryu","year":"2011","journal-title":"J Clin Lipidol"},{"issue":"10","key":"10.1016\/j.numecd.2018.01.012_bib49","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1161\/ATVBAHA.107.147280","article-title":"Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2","volume":"27","author":"Saougos","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"23 Suppl 1","key":"10.1016\/j.numecd.2018.01.012_bib50","first-page":"III39","article-title":"Beneficial cardiovascular pleiotropic effects of statins","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.numecd.2018.01.012_bib51","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/CIRCULATIONAHA.108.771899","article-title":"Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque","volume":"118","author":"Serruys","year":"2008","journal-title":"Circulation"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475318300474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475318300474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T20:20:20Z","timestamp":1660422020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475318300474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0939475318300474"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2018.01.012","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein-associated phospholipase A\u2082 activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2018.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}